A clinical assessment comes first
The visit reviews opioid use history, recent fentanyl exposure, withdrawal timing, prior treatment, medications, and safety concerns before a plan is made.
Approved addiction medicines have specific indications and different starting requirements. A medicine used for opioids is not automatically suitable for alcohol, stimulants, cannabis or gambling. The evaluation matches the diagnosed disorder, treatment goal and health history to the options.
OUD options include buprenorphine, methadone and naltrexone pathways. AUD options include naltrexone, acamprosate and disulfiram. Tobacco treatment has a different group of medicines. Stimulant and cannabis use disorders do not have an FDA-approved medication, although selected off-label treatment may be discussed.
Consider daily versus administered medication, kidney and liver health, opioid exposure, withdrawal, interactions, monitoring and the actual access pathway. Price or visit frequency alone does not decide suitability.
Treatment for opioid use disorder starts with an assessment of opioid use, withdrawal, overdose risk and what you want to change. Medicines can reduce withdrawal or cravings and help protect recovery. Treatment can be appropriate after heroin, fentanyl, nonprescribed pills or problematic prescription opioid use. An evaluation is still useful if you are uncertain about the diagnosis or have returned to use after earlier treatment.
Buprenorphine and methadone activate opioid receptors in controlled ways; naltrexone blocks them and requires an opioid-free starting point. They have different entry requirements and do not offer an identical experience. Naloxone reverses an opioid overdose but is not ongoing OUD treatment. Withdrawal management by itself does not resolve the longer-term risk of relapse and overdose.
The clinician reviews frequency and route of use, loss of control, consequences, tolerance and withdrawal, while distinguishing prescribed use and physical dependence from OUD. Pregnancy, severe symptoms, intoxication, other substance use and health conditions affect the safest setting. Bring any current OUD prescription: transferring care does not necessarily mean starting over, but records and an assessment are needed.
Describe the last opioid use, uncertain pill contents, prior overdoses and current symptoms. Include alcohol, sedatives, stimulants and pain treatment. The clinician assesses whether an outpatient plan is safe or whether urgent, hospital or another level of care is needed. An overdose or unstable condition should not wait for an ordinary clinic appointment.
Compare buprenorphine, methadone and naltrexone against your clinical needs and preferences. Buprenorphine initiation needs a safe plan after recent opioid exposure. Methadone for OUD generally requires an opioid treatment program. Naltrexone requires detoxification and opioid-free assessment. A clinic should help with a suitable referral when the chosen treatment is outside its verified services.
Clarify formulation, pharmacy or injection logistics, return visits, monitoring and whom to call for access problems. Address pain and mental-health treatment at the same time. Discuss counseling, recovery support and barriers such as transportation, housing or work hours without assuming one service can provide every resource.
Have naloxone and an overdose-response plan. Identify what to do after missed medication, renewed use or hospital discharge. A return to use needs reassessment of symptoms, dose coverage and other risks; it should not be hidden because you fear the visit will be wasted.
Bring identification if required for registration, a medication list, pharmacy details, recent treatment records and relevant insurance information. Tell the clinician if you are nearly out of medication or cannot obtain it. Ask how the first prescription or injection is arranged and what follow-up is required. Do not take borrowed treatment or create an opioid-free interval without advice to prepare for the visit.
Call 911 for possible overdose, slow breathing, unresponsiveness, severe chest pain or collapse. Use available naloxone for suspected opioid overdose and follow the product instructions. Alcohol and sedatives can sharply increase risk with opioids or OUD medicines. After a period without opioids, tolerance can be lower, making return to previous use especially dangerous. Pregnancy, dehydration or uncontrolled withdrawal can require urgent assessment.
Ongoing visits review withdrawal, craving patterns, substance use, function and medication effects. Testing, when clinically appropriate, should help interpret the treatment picture; it is not a complete diagnosis by itself. Discuss whether the plan needs more support, a different formulation or another treatment setting. Effective medication may continue for a long time. Stopping requires a plan for relapse prevention and overdose safety.
Ask what the service actually provides: evaluation, ongoing prescribing, injections, counseling or referral. Confirm the specific location, appointment availability, fees and pharmacy or payer requirements. Same-day availability depends on assessment, the intended service and supply. If the requested medicine is unavailable, ask for a safe interim or referral plan rather than waiting without a next step.
An outpatient assessment identifies the substance or behavioral concern, current use, withdrawal and overdose risks, mental health, and the level of care needed. Treatment can include appropriate medication, counseling and practical support. Buprenorphine, methadone and naltrexone have different opioid-treatment pathways; alcohol and tobacco medicines differ, and gambling care is behavioral. Not every concern has an approved medicine, and outpatient care is not suitable for every withdrawal risk. Confirm the actual services and qualified clinicians at the selected program.
Arrange follow-up before discharge or before an existing prescription runs out, and tell the clinician the last doses, recent use and withdrawal symptoms. Opioid withdrawal, alcohol withdrawal and benzodiazepine withdrawal use different treatment plans; abruptly stopping alcohol or benzodiazepines can be dangerous. Multiple substances increase interaction and overdose risks. The clinician decides whether office care is safe or monitored withdrawal/higher-level care is needed.
An appropriate evaluation or follow-up may be possible by video when the clinician is authorized to treat you where you are physically located. The service must confirm age, eligibility and current prescribing requirements. A video visit does not guarantee a controlled-substance prescription. Some examinations and tests need an in-person visit. Provider-administered injections require the appropriate treatment setting. Ask intake where any ordered specimens must be collected. Tell intake your actual location and requested service.
Possible overdose is an emergency. Call 911 and use available naloxone. Do not wait for an appointment, insurance confirmation or a prescription. Naloxone may cause sudden withdrawal in a person dependent on opioids, but saving breathing takes priority. Emergency monitoring is required even after an apparent response. It does not make high-risk opioid or sedative combinations safe.
Ask a pharmacist or clinician about OTC and other local access pathways. Confirm the specific device, expiration and storage instructions. Keep it somewhere that the people likely to help can find it promptly. Do not assume instructions for one nasal spray or injectable product match every product.
A person who cannot be awakened or has slow, shallow or absent breathing may be having an overdose. Other signs can include choking or gurgling sounds and discolored lips or nails. If uncertain but an opioid overdose is possible, respond promptly rather than waiting for proof of what was taken.
Administer available naloxone according to the product instructions and call 911. Tell the dispatcher what is happening and follow instructions for breathing support or CPR. More naloxone may be needed, especially with fentanyl. Repeat according to the product directions and emergency guidance.
Stay with the person until help arrives. Breathing problems can return after apparent improvement because naloxone may wear off. Do not assume that waking up means emergency care is unnecessary. Once immediate safety is addressed, discuss treatment, access barriers and another naloxone supply.
The visit reviews opioid use history, recent fentanyl exposure, withdrawal timing, prior treatment, medications, and safety concerns before a plan is made.
Withdrawal management may be part of a larger picture, but ongoing medication treatment, follow-up, and overdose-risk planning often matter more for stability.
Buprenorphine-based care can support cravings, withdrawal timing, relapse-risk reduction, and longer-term follow-up.
Injectable options can fit some patients, but product choice depends on opioid-free timing, buprenorphine stabilization, coverage, and clinical review.
Bronx
932 E 174th St, Bronx, NY 10460
Local MAT access for patients in West Farms, Crotona Park East, and nearby Bronx neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone careQueens
37-15 23rd Ave, Astoria, NY 11105
Local MAT access for patients in Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Bronx
2063A Bartow Ave, Bronx, NY 10475
Local MAT access for patients in Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
Local MAT access for patients in Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Long Island
232 W Old Country Rd, Hicksville, NY 11801
Local MAT access for patients in Hicksville, Plainview, Bethpage, and nearby Nassau County communities, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
Local MAT access for patients in Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
Local MAT access for patients in Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Queens
30-07 36th Ave, Astoria, NY 11106
Local MAT access for patients in Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Long Island
135 Mineola Blvd, Mineola, NY 11501
Local MAT access for patients in Mineola, Garden City, Westbury, and nearby Nassau County communities, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Manhattan
259 1st Ave, New York, NY 10003
Local MAT access for patients in StuyTown, East Village, Gramercy, and nearby Manhattan neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
Local MAT access for patients in Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone careReview online Suboxone treatment options in NYC with Nao Medical, including telemedicine evaluation, insurance review, follow-up planning, and in-person backup when needed.
Find buprenorphine treatment for opioid use disorder in NYC with Nao Medical, including Suboxone care, induction planning, follow-up, insurance review, and local MAT locations.
Review naloxone access, overdose safety planning, and how naloxone fits with opioid addiction treatment, Suboxone, Sublocade, and Vivitrol care at Nao Medical.
Compare Suboxone, Sublocade, and Vivitrol treatment pathways in NYC with Nao Medical, including buprenorphine, monthly injections, opioid-free timing, insurance, and follow-up planning.
Private addiction medicine, counseling coordination, insurance review, and local follow-up across NYC and Long Island.
Medical review, counseling coordination, relapse-prevention planning, and Vivitrol or naltrexone discussion when appropriate.
Private assessment, counseling coordination, mental-health review, and specialized referral guidance when needed.
Documentation, testing, MAT, counseling, and probation or court paperwork can be reviewed when instructions are brought in writing.
Outpatient follow-up can help maintain medication, counseling, insurance, and relapse-prevention planning after discharge.
Individual counseling, group therapy planning, substance-use support and medication-treatment coordination.
Arrange an evaluation to discuss suitable care, preparation and follow-up with a clinician.
Review opioid treatment optionsNao Medical provides outpatient addiction care. The first visit can focus on the immediate clinical question and medication planning when relevant. When wanted or clinically recommended, the care plan can also include counseling, recovery support, and closer follow-up. Related information: outpatient addiction care.
Patients who want more support can add counseling, relapse-prevention work, care coordination, and recovery follow-up through the outpatient addiction program.
Coverage depends on your exact plan, clinician, location and service. Check participation and expected charges with the clinic and your insurer before booking. Review addiction-treatment insurance support
Content was updated August 2, 2026 from the cited sources and Nao Medical's current service information. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.